Skip to main content
. 2020 Apr 10;47(6):569–577. doi: 10.1111/1346-8138.15343

Figure 4.

Figure 4

Median (IQR) NAPSI scores and patient distribution of brodalumab dose and dosing interval at baseline, day 1, week 28 and week 108. IQR, interquartile range; NAPSI, Nail Psoriasis Severity Index; Q2W, every 2 weeks; Q4W, every 4 weeks.